Condition
Drug Refractory Epilepsy clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Drug Refractory Epilepsy clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Taiwan (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Seizure forecasting with subscalp EEG and wearables to guide epilepsy treatment
This trial will try using forecasts from a subscalp EEG device plus wearable data to help people with temporal-lobe focal epilepsy who have frequent disabling seizures predict and manage their seizures.
-
Using focused ultrasound to treat drug-resistant epilepsy
This study is testing whether focused ultrasound can help people with drug-resistant epilepsy by reducing their seizures when other medications haven't worked.
Related topics
Quick answers
How many Drug Refractory Epilepsy clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.